Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04793776 · ClinicalTrials.gov registry record · NA

Manage Emotions to Reduce Aggression (MERA)

A NA study of Stress Disorders, Post-Traumatic and Emotion Regulation, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
204
Enrollment target
2
Study locations

NCT04793776: Recruiting NA study of Stress Disorders, Post-Traumatic and Emotion Regulation, sponsored by VA Office of Research and Development.

NCT04793776 is a NA study of Stress Disorders, Post-Traumatic and Emotion Regulation that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 204 participants, above the 153-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (33% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04793776, a NA study of Stress Disorders, Post-Traumatic and Emotion Regulation, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
204 participants
Enrollment target
2
Study locations

Study Summary

PTSD is one of the most prevalent mental health conditions affecting Veterans who have served since 9/11. Veterans with posttraumatic stress disorder (PTSD) report difficulty controlling impulsive aggression (IA). An inability to manage one's emotions (emotion dysregulation) is an underlying mechanism of IA. Reducing IA and increasing use of PTSD evidence-based psychotherapies are two critical missions for the Veterans Health Administration. The proposed research supports these missions by comparing a 3- session emotion regulation treatment (Manage Emotions to Reduce Aggression) to a control group in order to determine if MERA can reduce IA and prepare Veterans for PTSD treatment. By enhancing Veterans' abilities to cope with trauma-related emotions and feel equipped to initiate PTSD treatments, this research aims to help Veterans decrease IA and ultimately recover from PTSD.

Primary Outcome

Overt Aggression Scale is a 17-item self-report measure that assesses frequency of verbal and physical aggression against self, other, and objects and while driving over the past week. Veterans' self-reported aggressive acts will be summed to create an OAA total score. Minimum score = 0; there is no maximum score as Veterans can report as many episodes of aggression as they engage in.

Interventions

  • BEHAVIORAL Manage Emotions to Reduce Aggression
  • BEHAVIORAL Present Centered Psychotherapy

Study Locations (2)

Florida

  • James A. Haley Veterans' Hospital, Tampa, FL - Tampa

Texas

  • Michael E. DeBakey VA Medical Center, Houston, TX - Houston

Trial Details

FieldValue
Enrollment Target 204 participants
Start Date 2022-01-03
Est. Completion 2026-06-30
Phase NA
VA Office of Research and Development

1,668 total trials

What NCT04793776 shows while recruiting

NCT04793776 is an interventional study that assigns participants to a tested intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap, above the 153-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (33% higher).

The record links to 3 conditions, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 2 interventions - of which Manage Emotions to Reduce Aggression is the first listed.

NCT04793776 reports a single indexed study location in Florida, Texas.

Frequently Asked Questions

What is clinical trial NCT04793776 about?

NCT04793776 is a clinical study titled "Manage Emotions to Reduce Aggression (MERA)". PTSD is one of the most prevalent mental health conditions affecting Veterans who have served since 9/11. Veterans with posttraumatic stress disorder (PTSD) report difficulty controlling impulsive aggression (IA). An inability to manage one's emotions (emotion dysregulation) is an underlying mechani...

What is the current status of trial NCT04793776?

This trial is currently recruiting. It is a NA study. The enrollment target is 204 participants. The study started on 2022-01-03. Estimated completion is 2026-06-30.

What conditions does trial NCT04793776 study?

This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic, Emotion Regulation, Aggression.

What interventions are being tested in trial NCT04793776?

The interventions under investigation include: Manage Emotions to Reduce Aggression (BEHAVIORAL), Present Centered Psychotherapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT04793776?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04793776 being conducted?

This trial has 2 study locations across Florida, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress Disorders, Post-Traumatic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04793776's enrollment target sits among peer trials

204 13th of 66 higher than 54 of 66 other Stress Disorders, Post-Traumatic trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stress Disorders, Post-Traumatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03481010 · 204 participants · NA

    Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology

  • NCT04249830 · 204 participants · NA

    Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults

  • NCT04503395 · 204 participants · NA

    ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES

  • NCT05155163 · 204 participants · NA

    Stepped Care for Patients to Optimize Whole Recovery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04793776, the US trial registry maintained by the National Library of Medicine. NCT04793776 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.